Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues.
Despite successful treatment of Parkinson's disease (PD) with a wide variety of symptomatic therapy, the disease continues to progress and drug-resistance symptoms become the predominant factors producing the disability of PD patients. Neuroprotective therapies have been tested, but clinically effective drugs have not been found yet. New insights gained from studies of genetic forms of PD point to the common pathogenic mechanisms that have been suspected in sporadic forms of the disease and may provide new approaches for the future neuroprotective therapies.
Lin
William
W
Committees on Neurobiology and Molecular Medicine, Departments of Neurology and Neurobiology, Pharmacology, & Physiology, The University of Chicago, USA.
Kang
Un Jung
UJ
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8968-73
12084935
Curr Opin Neurol. 2000 Aug;13(4):427-30
10970060
Science. 1997 Jun 27;276(5321):2045-7
9197268
Free Radic Biol Med. 1993 Aug;15(2):169-79
8397142
Nature. 1998 Oct 1;395(6701):451-2
9774100
Ann Neurol. 2004 Apr;55(4):512-21
15048890
Mol Ther. 2005 Jan;11(1):80-8
15585408
Science. 2003 Jan 10;299(5604):256-9
12446870
Ann N Y Acad Sci. 2003 Jun;991:189-98
12846987
Life Sci. 1987 Feb 23;40(8):721-9
3100899
Am J Hum Genet. 2005 Aug;77(2):252-64
15986317
J Biol Chem. 1986 Jun 15;261(17):7585-7
3486869
Neurology. 2005 May 10;64(9):1655-6
15883340
Nat Genet. 1999 Sep;23(1):47-51
10471497
JAMA. 2000 May 24-31;283(20):2674-9
10819950
Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13891-6
15353588
Science. 2003 Oct 31;302(5646):841
14593171
Neurology. 1992 Apr;42(4 Suppl 4):13-26; discussion 41-8
1584429
Mol Cell. 2004 Apr 9;14(1):81-93
15068805
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13354-9
11078524
N Engl J Med. 2004 Dec 9;351(24):2498-508
15590952
N Engl J Med. 1993 Jan 21;328(3):176-83
8417384
Arch Neurol. 2004 Apr;61(4):561-6
15096406
Adv Neurol. 1993;60:600-8
8380528
Biochemistry. 1998 Mar 10;37(10):3358-68
9521656
J Biol Chem. 2002 Jan 18;277(3):1641-4
11707429
Arch Neurol. 2003 Aug;60(8):1059-64
12925360
J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1217-21
16107354
Ann Neurol. 2003 Jul;54(1):93-101
12838524
Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9074-8
1409604
J Biol Chem. 2001 Sep 14;276(37):34402-7
11447224
Nat Med. 2002 Jun;8(6):600-6
12042811
Neurol Clin. 1996 May;14(2):317-35
8827174
Hum Mol Genet. 2001 Apr 15;10(9):919-26
11309365
Nat Genet. 1998 Feb;18(2):106-8
9462735
Neurology. 2002 Feb 26;58(4):581-8
11865136
Neurology. 2005 Feb 22;64(4):664-9
15728289
Exp Neurol. 1999 May;157(1):142-9
10222117
Neurology. 2001 Jun 12;56(11):1559-64
11402115
Arch Neurol. 1989 Oct;46(10):1052-60
2508608
Ann Neurol. 1996 Jan;39(1):29-36
8572663
Ann Neurol. 2003;53 Suppl 3:S149-57; discussion S157-9
12666106
Neuron. 2005 Feb 17;45(4):489-96
15721235
J Biol Chem. 2004 May 14;279(20):20699-707
14742431
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5473-8
12702778
Proc Natl Acad Sci U S A. 1985 Apr;82(7):2173-7
3872460
J Neural Transm Suppl. 1999;56:1-29
10370901
Ann Neurol. 1997 Aug;42(2):261-4
9266740
PLoS Biol. 2004 Nov;2(11):e362
15502874
Science. 2000 Feb 18;287(5456):1265-9
10678833
Brain. 1992 Apr;115 ( Pt 2):333-42
1606472
JAMA. 2002 Apr 3;287(13):1653-61
11926889
J Biol Chem. 2004 Apr 30;279(18):18614-22
14985362
Neuroreport. 1999 Feb 5;10(2):427-9
10203348
Curr Opin Neurol. 2005 Aug;18(4):363-9
16003110
Neuron. 2004 Nov 18;44(4):601-7
15541309
Lancet. 1989 Jun 3;1(8649):1269
2566813
J Biol Chem. 2005 Jun 3;280(22):21418-26
15799973
Brain Res. 1998 Feb 2;783(1):109-14
9479058
Ann Neurol. 2004 Feb;55(2):164-73
14755719
Neurology. 2001 Feb 27;56(4):455-62
11222787
J Neurosci Res. 2005 Jan 1-15;79(1-2):172-9
15573406
Brain. 1991 Oct;114 ( Pt 5):2283-301
1933245
Prog Neuropsychopharmacol Biol Psychiatry. 1996 Oct;20(7):1159-70
8938817
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9256-61
12855764
N Engl J Med. 1989 Nov 16;321(20):1364-71
2509910
J Neurosci. 2001 Dec 15;21(24):9549-60
11739566
Neurobiol Dis. 2005 Feb;18(1):19-31
15649693
Neurobiol Dis. 2002 Jul;10(2):119-27
12127150
Brain Res. 1997 Apr 4;753(1):157-62
9125443
J Neurochem. 2003 Feb;84(3):491-502
12558969
Am J Hum Genet. 1997 Mar;60(3):588-96
9042918
Science. 2001 Nov 9;294(5545):1346-9
11701929
Neurol Clin. 2004 Oct;22(3 Suppl):S1-S17
15501359
Nature. 1998 Apr 9;392(6676):605-8
9560156
Biochemistry. 1996 May 28;35(21):6735-44
8639624
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):571-6
10639120
Lancet Neurol. 2005 Jun;4(6):362-5
15907740
J Neurochem. 2001 Jul;78(2):374-83
11461973
Ann Neurol. 2005 Feb;57(2):197-203
15668964
Neurology. 2003 Dec 9;61(11):1557-61
14663042
Neuron. 2002 Dec 19;36(6):1007-19
12495618
Brain Res. 2001 Jul 6;906(1-2):135-42
11430870
Mov Disord. 2005 Jun;20(6):653-64
15719422
Mol Pharmacol. 2000 Aug;58(2):271-8
10908294
Science. 2004 May 21;304(5674):1158-60
15087508
J Neurochem. 1999 Dec;73(6):2546-54
10582617
Trends Pharmacol Sci. 1999 Oct;20(10):424-9
10498956
J Biol Chem. 2004 Dec 10;279(50):51783-92
15469939
J Biol Chem. 1998 Feb 6;273(6):3756-64
9452508
Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5703-8
15824318
Science. 2002 Feb 1;295(5556):865-8
11823645
J Biol Chem. 2005 Jan 28;280(4):2873-8
15556931
Arch Neurol. 2002 Oct;59(10):1541-50
12374491
Trends Neurosci. 2001 Nov;24(11 Suppl):S49-55
11881746
Free Radic Res. 2001 Sep;35(3):301-10
11697128
Eur Neurol. 2005;53(1):15-21
15627775
J Neural Transm (Vienna). 2004 Dec;111(12):1543-73
15455214
J Biol Chem. 2003 Oct 31;278(44):43628-35
12930822
Neurology. 2003 Apr 22;60(8):1234-40
12707423
J Pharmacol Exp Ther. 1999 Feb;288(2):421-7
9918541
Exp Neurol. 1999 Feb;155(2):268-73
10072302
J Neurochem. 2000 Jun;74(6):2305-14
10820190
J Biol Chem. 1999 Jun 4;274(23):16188-97
10347173
Nat Genet. 2000 Jul;25(3):302-5
10888878
Nat Neurosci. 2000 Dec;3(12):1301-6
11100151
Nat Rev Mol Cell Biol. 2003 Mar;4(3):181-91
12612637